Innate Pharma Correlations
| IPHA Stock | USD 1.78 0.04 2.20% |
The current 90-days correlation between Innate Pharma and Cardiff Oncology is 0.01 (i.e., Significant diversification). The correlation of Innate Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Innate Pharma Correlation With Market
Very good diversification
The correlation between Innate Pharma and DJI is -0.34 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Innate Stock
| 0.62 | ENSC | Ensysce Biosciences | PairCorr |
| 0.63 | AIM | AIM ImmunoTech | PairCorr |
| 0.62 | XBIO | Xenetic Biosciences | PairCorr |
| 0.67 | CUE | Cue Biopharma | PairCorr |
| 0.66 | HURA | TuHURA Biosciences | PairCorr |
| 0.64 | NTRB | Nutriband | PairCorr |
| 0.65 | PCSA | Processa Pharmaceuticals | PairCorr |
Moving against Innate Stock
| 0.62 | VYNE | Vyne Therapeutics | PairCorr |
| 0.56 | FBIO | Fortress Biotech | PairCorr |
| 0.56 | KOD | Kodiak Sciences | PairCorr |
| 0.5 | VRTX | Vertex Pharmaceuticals Earnings Call Tomorrow | PairCorr |
| 0.5 | KPTI | Karyopharm Therapeutics | PairCorr |
| 0.35 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
| 0.58 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.52 | NRIX | Nurix Therapeutics | PairCorr |
| 0.38 | PLRZ | Polyrizon Ordinary | PairCorr |
| 0.33 | NXTC | NextCure | PairCorr |
| 0.33 | QTTB | Q32 Bio | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Innate Stock performing well and Innate Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Innate Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CRDF | 3.88 | (0.36) | 0.00 | (0.10) | 0.00 | 9.28 | 45.59 | |||
| RANI | 4.59 | (0.50) | 0.00 | (0.17) | 0.00 | 9.28 | 63.72 | |||
| MIST | 3.14 | 0.15 | 0.03 | 0.21 | 4.18 | 6.15 | 34.31 | |||
| CGEN | 2.92 | 0.12 | 0.03 | 0.19 | 3.01 | 7.27 | 22.26 | |||
| CRBP | 3.00 | (0.97) | 0.00 | 4.84 | 0.00 | 4.60 | 26.74 | |||
| MOLN | 2.90 | 0.37 | 0.09 | (6.82) | 3.30 | 7.46 | 26.47 | |||
| CYBN | 3.28 | 0.22 | 0.05 | (3.59) | 3.62 | 6.06 | 18.15 | |||
| NVCT | 2.91 | 0.40 | 0.13 | 0.35 | 2.98 | 7.20 | 17.53 | |||
| APLT | 7.14 | (2.81) | 0.00 | (0.66) | 0.00 | 10.00 | 83.66 | |||
| ELTX | 2.62 | (0.29) | 0.00 | (0.16) | 0.00 | 5.63 | 21.98 |
Innate Pharma Corporate Management
| Odile Belzunce | Vice Operations | Profile | |
| Marc Bonneville | Founder | Profile | |
| Jean Fourni | Founder | Profile | |
| Stephanie Cornen | Communication Relations | Profile | |
| Henry MSc | Vice Communication | Profile | |
| DVM MBA | VP Founder | Profile |